Author:
Ulutin Turgut,Sönmez Hüseyin,Üçışık Nergiz,Süer Selma,Bayram Çiǧdem,Kökoǧlu Emine,Sultuybek Gönül
Reference27 articles.
1. Moleuclar markers of hemostatic activation: Applications in the diagnosis of thrombosis and vascular and thrombotic disorders;Fareed;Clin App Thromb Hemost,1995
2. Oida K, Maeda H, Nakai T. Abnormal antithrombogenic function on endothelial cells in diabetes mellitus. In: King GL, Shigela Y, editors. Endothelial Cell Dysfunction Diabetes. Japan: Churchill Livingstone; 1994. p. 33–54.
3. Walenga JM, Fareed J, Messmore HL. Newer avenues in the monitoring of antithrombotic therapy: The role of automation. Semin Thromb Hemost 1983;9:346–54.
4. Messmore HL, Walenga JM, Fareed J. Molecular markers of platelet activation. Semin Thromb Hemost 1983;9(4):354–78.
5. Baver KA, Rosenberg RD. The pathophysiology of the prothrombotic state in humans: Insight gained from studies using markers of hemostatic system activation. Blood 1987;70:343–50.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献